查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1776809

医疗食品市场：全球产业分析、市场规模、份额、成长、趋势与未来预测（2025-2032）

Medical Foods Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 195 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球医疗食品市场的全面分析报告。该报告对关键市场动态进行了全面评估，包括市场驱动因素、趋势、机会和挑战，并对市场结构提供了深入的见解。报告提供了独家数据和统计数据，概述了全球医疗食品市场的预测成长轨迹（2025-2032 年）。

关键见解

  • 医疗食品市场规模（2025年）：255亿美元
  • 市场规模预测（以金额为准，2032年）：395亿美元
  • 全球市场成长率（2025-2032年复合年增长率）：6.5%

医疗食品市场-分析范围

医疗食品是专门为治疗疾病或病症而配製的膳食管理食品，这些疾病或病症具有独特的营养需求，无法透过常规饮食来满足。这些产品在医生监督下食用，常用于治疗阿兹海默症、慢性肾臟病、代谢紊乱和胃肠道疾病等疾病。医疗食品市场服务于医院、诊所、长期照护机构和家庭护理机构，提供各种形式的产品，例如粉剂、液体和胶囊。市场成长的驱动力包括慢性病盛行率的上升、人们对疾病特异性营养的认识的不断提高，以及需要有针对性饮食干预的全球人口老化。

市场成长动力：

全球医疗食品市场受多种关键因素驱动，其中包括日益加重的慢性病和文明病负担，这些疾病需要个人化营养疗法。阿兹海默症和帕金森氏症等神经系统疾病、糖尿病以及胃肠道疾病的盛行率不断上升，也推动了医疗食品需求的成长。此外，预防性医疗保健的转变，加上营养科学的进步和针对特异性疾病配方的开发，也支撑了市场的成长。将医疗食品视为独立类别的法律规范也为产品开发和商业化提供了一个稳定的环境。

市场限制：

儘管前景光明，医疗食品市场仍面临着许多挑战，例如严格的监管要求、高昂的产品开发成本以及有限的报销框架。临床检验和科学有效性证明的需求增加了产品上市所需的时间和成本。此外，患者和医疗保健提供者对医疗食品的角色和益处缺乏认识，阻碍了市场渗透，尤其是在新兴市场。全球监管分类和标籤要求的差异也阻碍了製造商的国际扩张。

市场机会：

医疗食品市场蕴藏着显着的成长机会，这得益于研发投入的不断增加、营养基因组学的进步以及个性化营养需求的不断增长。电商平台和远端医疗服务的扩展将提升医疗食品的可近性，尤其对于居家管理慢性病的患者而言。此外，对肠道健康、微生物组调节和免疫支持的日益关注将为医疗食品的应用开闢新的途径。製药、生物技术和营养相关企业之间的策略合作将进一步促进产品创新和市场扩张。弥补临床教育方面的差距并简化监管途径对于充分发挥市场的潜力至关重要。

本报告回答的关键问题

  • 推动全球医疗食品市场成长的关键因素有哪些？
  • 哪些疾病领域和配方正在影响医疗食品的开发和采用？
  • 监管政策如何影响各地区的医疗食品商业化？
  • 医疗食品市场的主要企业有哪些？他们采取什么策略来扩大其市场影响力？
  • 全球医疗食品市场有哪些新趋势和未来前景？

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长前景
  • COVID-19影响分析
  • 预测因子：相关性和影响力

第三章 加值分析

  • 招募表格分析
  • 监管状况
  • 疾病流行病学
  • 赎回方案
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第四章全球医疗食品市场展望：

  • 主要亮点
    • 市场规模及年成长率（以金额为准）
    • 绝对的商机
  • 市场规模分析与预测（以金额为准）
    • 历史市场规模分析（以金额为准，2019-2024）
    • 市场规模分析与预测（以金额为准，2025-2032）
  • 全球医疗食品市场形态展望
    • 引言/主要发现
    • 按类型分類的历史市场规模分析（以金额为准，2019-2024）
    • 按类型分類的市场规模分析与预测（以金额为准，2025-2032）
      • 锭剂
      • 粉末
      • 液体
      • 其他的
    • 市场吸引力分析：依形状
  • 全球医疗食品市场应用前景
    • 引言/主要发现
    • 按应用分類的历史市场规模分析（以金额为准，2019-2024）
    • 按应用分類的市场规模分析和预测（以金额为准，2025-2032）
      • 慢性肾臟病（CKD）
      • 阿兹海默症
      • 糖尿病神经病变
      • 注意力不足过动症（ADHD）
      • 忧郁症
      • 罕见疾病
      • 癌症
      • 其他的
    • 市场吸引力分析：按应用
  • 全球医疗食品市场按销售管道展望
    • 引言/主要发现
    • 按销售管道分類的历史市场规模分析（以金额为准，2019-2024 年）
    • 按销售管道分類的市场规模分析和预测（以金额为准，2025-2032 年）
      • 超级市场和大卖场
      • 线上管道
      • 药局和药房
      • 医院
      • 其他的
    • 按销售管道进行市场吸引力分析

第五章 全球医疗食品市场区域展望

  • 主要亮点
  • 按地区分類的历史市场规模分析（以金额为准，2019-2024 年）
  • 各地区市场规模分析及预测（以金额为准，2025-2032）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：区域

第六章北美医疗食品市场展望

第七章欧洲医疗食品市场展望

第八章 东亚医疗食品市场展望

第九章 南亚和大洋洲医疗食品市场展望

第十章拉丁美洲医疗食品市场展望

第11章中东与非洲医疗食品市场展望

第十二章竞争格局

  • 市场占有率分析（2024年）
  • 市场结构
    • 竞争强度图：按市场
    • 竞争仪錶板
  • 公司简介（详情：概述、财务状况、策略、最新发展）
    • Nestle Health Science
    • Abbott Laboratories
    • Danone SA（Nutricia Advanced Medical Nutrition）
    • Fresenius Kabi AG
    • Mead Johnson Nutrition（part of Reckitt Benckiser）
    • Primus Pharmaceuticals, Inc.
    • Targeted Medical Pharma, Inc.
    • Medtrition, Inc.
    • Metagenics, Inc.
    • Alfasigma SpA
    • Ajinomoto Cambrooke, Inc.
    • BioMedical Nutrition, Inc.
    • Meiji Holdings Co., Ltd.
    • B. Braun Melsungen AG
    • Entia Biosciences Inc.
    • Others

第十三章 附录

  • 调查方法
  • 调查前提
  • 首字母缩写和简称
简介目录
Product Code: PMRREP26854

Persistence Market Research has recently released a comprehensive report on the worldwide market for medical foods. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global medical foods market from 2025 to 2032.

Key Insights:

  • Medical Foods Market Size (2025E): USD 25.5 Billion
  • Projected Market Value (2032F): USD 39.5 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.5%

Medical Foods Market - Report Scope:

Medical foods are specially formulated and intended for the dietary management of diseases or conditions that have distinctive nutritional needs not met by normal diets. These products are consumed under medical supervision and are typically used for conditions such as Alzheimer's disease, chronic kidney disease, metabolic disorders, and gastrointestinal diseases. The medical foods market serves hospitals, clinics, long-term care facilities, and homecare settings, offering products in various forms such as powders, liquids, and capsules. Market growth is driven by the rising prevalence of chronic diseases, increased awareness of disease-specific nutrition, and an aging global population requiring targeted dietary interventions.

Market Growth Drivers:

The global medical foods market is propelled by several key factors, including the growing burden of chronic and lifestyle-related diseases, which demand personalized nutritional therapies. Rising incidences of neurological disorders such as Alzheimer's and Parkinson's disease, along with diabetes and gastrointestinal conditions, contribute to the increased demand for medical foods. Additionally, the shift toward preventative healthcare, coupled with advances in nutritional science and the development of disease-specific formulations, supports market growth. Regulatory frameworks recognizing medical foods as a distinct category also provide a stable environment for product development and commercialization.

Market Restraints:

Despite a promising outlook, the medical foods market faces challenges such as stringent regulatory requirements, high product development costs, and limited reimbursement frameworks. The need for clinical validation and scientific substantiation for efficacy adds to the time and expense required to bring products to market. Furthermore, lack of awareness among patients and healthcare providers regarding the role and benefits of medical foods can hinder market penetration, especially in developing regions. Variability in global regulatory classifications and labeling requirements also poses barriers to international expansion for manufacturers.

Market Opportunities:

The medical foods market presents notable growth opportunities driven by increasing R&D investment, advances in nutrigenomics, and growing demand for personalized nutrition. The expansion of e-commerce platforms and telehealth services enhances access to medical foods, particularly for patients managing chronic conditions at home. Additionally, the rising focus on gut health, microbiome modulation, and immune support opens new avenues for medical food applications. Strategic collaborations between pharmaceutical, biotech, and nutrition companies further contribute to product innovation and market expansion. Addressing gaps in clinical education and streamlining regulatory pathways are critical to unlocking the full potential of this market.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the medical foods market globally?
  • Which disease areas and formulations are influencing medical food development and adoption?
  • How are regulatory policies shaping the commercialization of medical foods across different regions?
  • Who are the key players in the medical foods market, and what strategies are they employing to enhance their market presence?
  • What are the emerging trends and future outlook for the global medical foods market?

Competitive Intelligence and Business Strategy:

These companies invest significantly in developing disease-specific formulations, enhancing palatability, and improving nutritional delivery. Collaborations with academic institutions, healthcare professionals, and patient advocacy groups support market education and clinical integration. Mergers, acquisitions, and strategic partnerships enable portfolio diversification and geographic expansion, while digital health tools are increasingly leveraged to support patient compliance and remote monitoring.

Key Companies Profiled:

  • Nestle Health Science
  • Abbott Laboratories
  • Danone S.A. (Nutricia Advanced Medical Nutrition)
  • Fresenius Kabi AG
  • Mead Johnson Nutrition (part of Reckitt Benckiser)
  • Primus Pharmaceuticals, Inc.
  • Targeted Medical Pharma, Inc.
  • Medtrition, Inc.
  • Metagenics, Inc.
  • Alfasigma S.p.A.
  • Ajinomoto Cambrooke, Inc.
  • BioMedical Nutrition, Inc.
  • Meiji Holdings Co., Ltd.
  • B. Braun Melsungen AG
  • Entia Biosciences Inc.
  • Others

Medical Foods Market Research Segmentation:

The medical foods market encompasses a diverse range of product types, disease targets, routes of administration, and end-user segments, addressing various patient populations.

By Form

  • Pills
  • Powders
  • Liquids
  • Others

By Application

  • Chronic Kidney Disease (CKD)
  • Alzheimer's Disease
  • Diabetic Neuropathy
  • ADHD (Attention Deficit Hyperactivity Disorder)
  • Depression
  • Orphan Diseases
  • Cancer
  • Others

By Sales Channels

  • Supermarkets & Hypermarkets
  • Online Channels
  • Drug Stores & Pharmacies
  • Hospitals
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Medical Foods Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Form Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Disease Epidemiology
  • 3.4. Reimbursement Scenario
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Medical Foods Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Medical Foods Market Outlook: Form
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Form, 2019-2024
    • 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
      • 4.3.3.1. Pills
      • 4.3.3.2. Powders
      • 4.3.3.3. Liquids
      • 4.3.3.4. Others
    • 4.3.4. Market Attractiveness Analysis: Form
  • 4.4. Global Medical Foods Market Outlook: Application
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
    • 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      • 4.4.3.1. Chronic Kidney Disease (CKD)
      • 4.4.3.2. Alzheimer's Disease
      • 4.4.3.3. Diabetic Neuropathy
      • 4.4.3.4. ADHD (attention deficit hyperactivity disorder)
      • 4.4.3.5. Depression
      • 4.4.3.6. Orphan Diseases
      • 4.4.3.7. Cancer
      • 4.4.3.8. Others
    • 4.4.4. Market Attractiveness Analysis: Application
  • 4.5. Global Medical Foods Market Outlook: Sales Channel
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Sales Channel, 2019-2024
    • 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By Sales Channel, 2025-2032
      • 4.5.3.1. Supermarkets & Hypermarkets
      • 4.5.3.2. Online Channels
      • 4.5.3.3. Drug Stores & Pharmacies
      • 4.5.3.4. Hospitals
      • 4.5.3.5. Others
    • 4.5.4. Market Attractiveness Analysis: Sales Channel

5. Global Medical Foods Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Medical Foods Market Outlook

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Form
    • 6.2.3. By Application
    • 6.2.4. By Sales Channel
  • 6.3. Market Size (US$ Bn) Analysis and Forecast By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
    • 6.4.1. Pills
    • 6.4.2. Powders
    • 6.4.3. Liquids
    • 6.4.4. Others
  • 6.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 6.5.1. Chronic Kidney Disease (CKD)
    • 6.5.2. Alzheimer's Disease
    • 6.5.3. Diabetic Neuropathy
    • 6.5.4. ADHD (attention deficit hyperactivity disorder)
    • 6.5.5. Depression
    • 6.5.6. Orphan Diseases
    • 6.5.7. Cancer
    • 6.5.8. Others
  • 6.6. Market Size (US$ Bn) Analysis and Forecast, By Sales Channel, 2025-2032
    • 6.6.1. Supermarkets & Hypermarkets
    • 6.6.2. Online Channels
    • 6.6.3. Drug Stores & Pharmacies
    • 6.6.4. Hospitals
    • 6.6.5. Others
  • 6.7. Market Attractiveness Analysis

7. Europe Medical Foods Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Form
    • 7.2.3. By Application
    • 7.2.4. By Sales Channel
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
    • 7.4.1. Pills
    • 7.4.2. Powders
    • 7.4.3. Liquids
    • 7.4.4. Others
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Chronic Kidney Disease (CKD)
    • 7.5.2. Alzheimer's Disease
    • 7.5.3. Diabetic Neuropathy
    • 7.5.4. ADHD (attention deficit hyperactivity disorder)
    • 7.5.5. Depression
    • 7.5.6. Orphan Diseases
    • 7.5.7. Cancer
    • 7.5.8. Others
  • 7.6. Market Size (US$ Bn) Analysis and Forecast, By Sales Channel, 2025-2032
    • 7.6.1. Supermarkets & Hypermarkets
    • 7.6.2. Online Channels
    • 7.6.3. Drug Stores & Pharmacies
    • 7.6.4. Hospitals
    • 7.6.5. Others
  • 7.7. Market Attractiveness Analysis

8. East Asia Medical Foods Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Form
    • 8.2.3. By Application
    • 8.2.4. By Sales Channel
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
    • 8.4.1. Pills
    • 8.4.2. Powders
    • 8.4.3. Liquids
    • 8.4.4. Others
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 8.5.1. Chronic Kidney Disease (CKD)
    • 8.5.2. Alzheimer's Disease
    • 8.5.3. Diabetic Neuropathy
    • 8.5.4. ADHD (attention deficit hyperactivity disorder)
    • 8.5.5. Depression
    • 8.5.6. Orphan Diseases
    • 8.5.7. Cancer
    • 8.5.8. Others
  • 8.6. Market Size (US$ Bn) Analysis and Forecast, By Sales Channel, 2025-2032
    • 8.6.1. Supermarkets & Hypermarkets
    • 8.6.2. Online Channels
    • 8.6.3. Drug Stores & Pharmacies
    • 8.6.4. Hospitals
    • 8.6.5. Others
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Medical Foods Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Form
    • 9.2.3. By Application
    • 9.2.4. By Sales Channel
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
    • 9.4.1. Pills
    • 9.4.2. Powders
    • 9.4.3. Liquids
    • 9.4.4. Others
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Chronic Kidney Disease (CKD)
    • 9.5.2. Alzheimer's Disease
    • 9.5.3. Diabetic Neuropathy
    • 9.5.4. ADHD (attention deficit hyperactivity disorder)
    • 9.5.5. Depression
    • 9.5.6. Orphan Diseases
    • 9.5.7. Cancer
    • 9.5.8. Others
  • 9.6. Market Size (US$ Bn) Analysis and Forecast, By Sales Channel, 2025-2032
    • 9.6.1. Supermarkets & Hypermarkets
    • 9.6.2. Online Channels
    • 9.6.3. Drug Stores & Pharmacies
    • 9.6.4. Hospitals
    • 9.6.5. Others
  • 9.7. Market Attractiveness Analysis

10. Latin America Medical Foods Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Form
    • 10.2.3. By Application
    • 10.2.4. By Sales Channel
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
    • 10.4.1. Pills
    • 10.4.2. Powders
    • 10.4.3. Liquids
    • 10.4.4. Others
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Chronic Kidney Disease (CKD)
    • 10.5.2. Alzheimer's Disease
    • 10.5.3. Diabetic Neuropathy
    • 10.5.4. ADHD (attention deficit hyperactivity disorder)
    • 10.5.5. Depression
    • 10.5.6. Orphan Diseases
    • 10.5.7. Cancer
    • 10.5.8. Others
  • 10.6. Market Size (US$ Bn) Analysis and Forecast, By Sales Channel, 2025-2032
    • 10.6.1. Supermarkets & Hypermarkets
    • 10.6.2. Online Channels
    • 10.6.3. Drug Stores & Pharmacies
    • 10.6.4. Hospitals
    • 10.6.5. Others
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Medical Foods Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Form
    • 11.2.3. By Application
    • 11.2.4. By Sales Channel
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
    • 11.4.1. Pills
    • 11.4.2. Powders
    • 11.4.3. Liquids
    • 11.4.4. Others
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Chronic Kidney Disease (CKD)
    • 11.5.2. Alzheimer's Disease
    • 11.5.3. Diabetic Neuropathy
    • 11.5.4. ADHD (attention deficit hyperactivity disorder)
    • 11.5.5. Depression
    • 11.5.6. Orphan Diseases
    • 11.5.7. Cancer
    • 11.5.8. Others
  • 11.6. Market Size (US$ Bn) Analysis and Forecast, By Sales Channel, 2025-2032
    • 11.6.1. Supermarkets & Hypermarkets
    • 11.6.2. Online Channels
    • 11.6.3. Drug Stores & Pharmacies
    • 11.6.4. Hospitals
    • 11.6.5. Others
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Nestle Health Science
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Form
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Abbott Laboratories
    • 12.3.3. Danone S.A. (Nutricia Advanced Medical Nutrition)
    • 12.3.4. Fresenius Kabi AG
    • 12.3.5. Mead Johnson Nutrition (part of Reckitt Benckiser)
    • 12.3.6. Primus Pharmaceuticals, Inc.
    • 12.3.7. Targeted Medical Pharma, Inc.
    • 12.3.8. Medtrition, Inc.
    • 12.3.9. Metagenics, Inc.
    • 12.3.10. Alfasigma S.p.A.
    • 12.3.11. Ajinomoto Cambrooke, Inc.
    • 12.3.12. BioMedical Nutrition, Inc.
    • 12.3.13. Meiji Holdings Co., Ltd.
    • 12.3.14. B. Braun Melsungen AG
    • 12.3.15. Entia Biosciences Inc.
    • 12.3.16. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations